Achim Seyr

#PrivateEquity momentum has slowed down this year, with buyout deal count tracking down 4% globally compared to 2023. Although global deal value is projected to reach $521 billion, an 18% increase over 2023, this increase is due to a higher average deal size, not more deals. To find out more, check out our midyear update: https://atbain.co/4eaOmN7

3

Discover insights from Emilio Domingo, Head of Private Equity in the UK, as he discusses the outlook for private equity in 2024 in our latest webinar recording: Global Private Equity Report: UK and Europe deep dive.

1

In every fast-growing industry, mergers and acquisitions have helped high-potential solutions gain the operational experience needed to make a larger impact. Moreover, all-in-one platforms that offer holistic services are highly sought after. Managers and executives seek the highest possible value at the best price, an equation that can only be satisfied by companies that integrate multiple solutions into one product.   So, indeed, I agree with Michael Schelper that M&As in #Healthcare can create added value for investors, hospitals, and end-consumers. Two great companies with a big vision will always make a bigger impact together, rather than alone. #DataDrivenSurgery #Caresyntax #HealthcareInnovation

22

👣 Two major steps towards European Health Assurance ⭐ We are thrilled to support both Doccla and Neko Health expanding their footprint across Europe this week. These two businesses are taking major steps to advance preventative care, critical for the delivery of Health Assurance. At General Catalyst, our European Health Assurance thesis is to build scaled businesses at the intersection of healthcare and technology across geographies. The health aspirations and care needs are the same for consumers and the vulnerabilities of the health systems are similar. However, the build is not easy; each country presents a unique set of challenges—distinct regulatory frameworks, differing care infrastructure, diverse payment models, and legacy technologies – that add complexity. But for the most ambitious, mission-driven European entrepreneurs, complex problems are the greatest opportunities! Born in Sweden, Doccla and Neko were built by Martin Ratz, Dag Larsson, Daniel Ek and Hjalmar Nilsonne respectively with big visions to scale across borders. While they operate at opposite sides of the acuity spectrum and have different approaches to reimbursement, they share an obsessive focus on building consumer-centric, technology-enhanced platforms that engage people in primary, secondary and tertiary preventive care. Just as most of the successful companies of the last decade have radically changed consumer behaviour, Doccla and Neko are standard bearers in a movement that will fundamentally transform how people approach their health. Since our investment, Doccla has scaled to serve over half of the NHS trusts, reducing emergency department visits by up to 60%. With a £35M Series B funding round, Doccla are primed to bring their virtual hospital solutions to France and Germany, bringing the same hospital-grade care to patients in the comfort of their home as in the UK. Neko has facilitated thousands of full body scans in Sweden and uncovered critical health issues that have spared many individuals. Now, with their expansion into the UK, they are cementing their position as the leading destination in Europe for consumers to gain a comprehensive understanding of their health. At General Catalyst, we are committed to creating, investing, partnering and operating to enhance the resilience of European healthcare. We see tremendous value in catalysing this European movement and invite founders, investors and traditional healthcare leaders from across the continent to join us in the pursuit of Health Assurance. The existing 'sick' care system is in a precarious state and can only be transformed into a more proactive, affordable and accessible one if we work together! Hemant Taneja, Jeannette zu Fürstenberg, Paul Kwan, Alexandre Momeni

115

3 Kommentare

This Series paper delves into the impact of digital tools on heart failure care, covering screening, diagnosis, treatment, and monitoring, and their potential for research. The rapid evolution of technology, global connectivity, and the digital shift in healthcare favor their integration. Despite available therapies, challenges persist, especially in low-to-middle-income countries. Establishing global clinical frameworks for these tools is vital as they reshape patient care and research. #epeeps #AmericanHeartAssociation #HeartRhythmSociety #HeartFailureSocietyofAmerica American Heart Association Heart Rhythm Society American College of Cardiology

31

1 Kommentar

🌟 The January 2024 Global Healthcare Overview by Deloitte highlights transformative trends that deeply resonate with our mission at Caresyntax. As we continue to make surgery safer and smarter through data-driven solutions, these insights are both future-oriented and impactful. The post-pandemic era has shown us the incredible potential of AI in healthcare. AI technologies are not just futuristic—they are here and now, revolutionizing patient interactions, streamlining processes, and freeing up clinicians' time. These benefits are generating annual savings of up to US$360 billion for hospitals in the USA. As stated by Deloitte, cost and affordability remain pressing issues, along with inflation and staffing shortages. Innovative solutions driven by #AI are essential for optimizing resources and reducing expenses. These technologies can also help address the increasing shortfall in healthcare workers, another important issue highlighted in the study. At Caresyntax, we are committed to harnessing the power of AI and data to drive smarter, safer, and more efficient surgical care. The future of healthcare is here, and we are proud to be leading the charge. https://lnkd.in/eMZRJVqG #HealthcareInnovation #AIinHealthcare #SurgicalIntelligence #HealthcareTransformation #DataDrivenCare

23